Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed with results

Key Signals

2 with results88% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (7)
P 1 (3)
P 2 (5)

Trial Status

Completed7
Recruiting7
Active Not Recruiting5
Withdrawn1
Not Yet Recruiting1
Terminated1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT05179486Recruiting

Molecular Epidemiology of Biliary Tree Cancers

NCT02713269Phase 2Active Not RecruitingPrimary

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

NCT07215624RecruitingPrimary

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

NCT04986566Not ApplicableActive Not RecruitingPrimary

Perioperative Telemonitoring to Optimize Cancer Care and Outcomes

NCT07283939Not ApplicableRecruiting

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

NCT02221700Not ApplicableActive Not Recruiting

Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies

NCT07456852Phase 1Not Yet RecruitingPrimary

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

NCT06855524Phase 2RecruitingPrimary

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer

NCT04505553Phase 2Completed

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

NCT04629677RecruitingPrimary

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

NCT00991094Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

NCT05107219Phase 1Active Not Recruiting

GCC Agonist Signal in the Small Intestine

NCT04501913Completed

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

NCT06374251Not ApplicableCompletedPrimary

Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers

NCT03800693Phase 2RecruitingPrimary

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

NCT05018208Completed

Remote Monitoring in Cancer Care: A Platform Study

NCT04111172Phase 2Active Not Recruiting

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

NCT03267524Not ApplicableCompleted

Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers

NCT03563352Withdrawn

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

NCT02192333Not ApplicableCompleted

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Scroll to load more

Research Network

Activity Timeline